http://www.kauppalehti.fi/4/i/eng/releases/press_release.jsp?selected=other&oid=20071001/11925307941970&lang=ENTamiflu sales down 60 % over Q3 last year.Doesnt bode well for relenza but you never know.
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint